# Allogene Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/allogene-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:46:26.520291+00:00 | | Last reviewed | 2026-10-16T04:46:26.520291+00:00 | ## Identity - Legal name: Allogene Therapeutics, Inc. - Display name: Allogene Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T06:11:25.462244+00:00 | | Completeness | 0.409 | | Record Quality | 0.841 | | Directors | 11 | | Committees | 4 | | Governance events | 19 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Arie Belldegrun, M.D.: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:5 - David Chang, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2018-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:6 - Deborah Messemer: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:7 - Elizabeth Barrett: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:8 - Franz Humer, Ph.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:9 - John DeYoung: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:10 - Joshua Kazam: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:11 - Owen Witte, M.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:12 - Stephen Mayo, Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:13 - Todd Sisitsky: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:14 - Vicki Sato, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:15 ## Committees - Audit (audit). Chair: Deborah Messemer. Members: Deborah Messemer (chair, current); Elizabeth Barrett (member, current). committee_id=alpha:committee:allogene-therapeutics-inc:audit - Audit · Chair; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Deborah Messemer (member, current). committee_id=alpha:committee:allogene-therapeutics-inc:audit-chair-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: John DeYoung (member, current). committee_id=alpha:committee:allogene-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: Deborah Messemer. Members: Deborah Messemer (chair, current); Todd Sisitsky (member, current). committee_id=alpha:committee:allogene-therapeutics-inc:nominating-and-governance ## Executive leadership - Derek Chang: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:17 - Earl Douglas: Senior Vice President, General Counsel and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:18 - Geoffrey Parker: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:19 - David Chang, M.D., Ph.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:16 ## Governance events - CEO_CHANGED: Derek Chang executive of Allogene Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:5qfkr012zx9go - GC_CHANGED: Earl Douglas executive of Allogene Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1peb5qw1jl8yx6 - CFO_CHANGED: Geoffrey Parker executive of Allogene Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:d73h3611hk41s - DIRECTOR_APPOINTED: Stephen Mayo, Ph.D. seat on Allogene Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:18ua8nc1emy8m2 - DIRECTOR_APPOINTED: Elizabeth Barrett seat on Allogene Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:vz339b19y2anr - DIRECTOR_APPOINTED: Vicki Sato, Ph.D. seat on Allogene Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:flsnqrd4gzln - COMMITTEE_MEMBER_ADDED: Elizabeth Barrett member of Audit, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:dv6aib40m7w9 - DIRECTOR_APPOINTED: David Chang, M.D., Ph.D. seat on Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:773k3hm9c27b - DIRECTOR_APPOINTED: Deborah Messemer seat on Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:17hkgq61yf540i - DIRECTOR_APPOINTED: Franz Humer, Ph.D. seat on Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:y2u1p81lu30qc - DIRECTOR_APPOINTED: John DeYoung seat on Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1uaimlqq5iy7s - DIRECTOR_APPOINTED: Owen Witte, M.D. seat on Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:huaatwd93t0a - DIRECTOR_APPOINTED: Todd Sisitsky seat on Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1ddbd9ymncqfg - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance · Chair committee of Allogene Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:n0ygjg1kdei9q - COMMITTEE_MEMBER_ADDED: Deborah Messemer member of Audit · Chair; Nominating and Governance · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:15a4ikppbqokh - COMMITTEE_MEMBER_ADDED: John DeYoung member of Compensation, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:sr5ji515l92m5 - COMMITTEE_MEMBER_ADDED: Todd Sisitsky member of Nominating and Governance, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1djwtecbm80f8 - DIRECTOR_APPOINTED: Arie Belldegrun, M.D. seat on Allogene Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1cbx7y58rktoz - DIRECTOR_APPOINTED: Joshua Kazam seat on Allogene Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:ikljrm1uk2urm ## Scoped resources - `alpha://company/allogene-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record - `alpha://company/allogene-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=identity - `alpha://company/allogene-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/allogene-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=board - `alpha://company/allogene-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=committees - `alpha://company/allogene-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=leadership - `alpha://company/allogene-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=ownership - `alpha://company/allogene-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=financials - `alpha://company/allogene-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/allogene-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=compensation - `alpha://company/allogene-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=governance - `alpha://company/allogene-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/allogene-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=audit - `alpha://company/allogene-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=legal - `alpha://company/allogene-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=risk - `alpha://company/allogene-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=cyber - `alpha://company/allogene-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/allogene-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=agents - `alpha://company/allogene-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/allogene-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=events - `alpha://company/allogene-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=relationships - `alpha://company/allogene-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=assessments - `alpha://company/allogene-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:deborah-messemer","name":"Deborah Messemer"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:elizabeth-barrett","name":"Elizabeth Barrett"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-deyoung","name":"John DeYoung"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:deborah-messemer","name":"Deborah Messemer"},"source_id":"board_seats"}` - Claim alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:todd-sisitsky","name":"Todd Sisitsky"},"source_id":"board_seats"}` ## Leadership - Arie Belldegrun, M.D.: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:5. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - David Chang, M.D., Ph.D.: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Deborah Messemer: Director, Audit · Chair; Nominating and Governance · Chair. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:7. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Elizabeth Barrett: Director, Audit. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Franz Humer, Ph.D.: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:9. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - John DeYoung: Director, Compensation. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Joshua Kazam: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Owen Witte, M.D.: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Stephen Mayo, Ph.D.: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Todd Sisitsky: Director, Nominating and Governance. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:14. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - Vicki Sato, Ph.D.: Director. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:15. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890. - David Chang, M.D., Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d7ea16c416f6c284f251bd72e921ee2eccd63fbc43e9f19d4e0e1a1dd5d9f026. - Derek Chang: President and Chief Executive Officer. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:17. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e359aa9adfd484ae58d99eb4dfb63c07024ecaf45119a809aaf1295f1b616d75. - Earl Douglas: Senior Vice President, General Counsel and Corporate Secretary. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:18. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:49f57b56db9669a6e5377a23b131b32c4f33cc0d52bccbd255a548a3fddfd7b9. - Geoffrey Parker: Chief Financial Officer. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:leadership_role:19. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a8e53f8022fc4e59cc536d4294344629256f3aa587b4d4744b940d9713a75d0. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Deborah Messemer; Members Deborah Messemer (Chair); Elizabeth Barrett. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. - Compensation: Chair not stated; Members John DeYoung. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. - Nominating and Governance: Chair Deborah Messemer; Members Deborah Messemer (Chair); Todd Sisitsky. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Allogene Therapeutics, Inc.. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df98055cad43227caad2761e4aa963bc386f8552b0fceee86687bd332e8ff498. ## Entity Status - Public listing published. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df98055cad43227caad2761e4aa963bc386f8552b0fceee86687bd332e8ff498. ## Published Fact - US. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df98055cad43227caad2761e4aa963bc386f8552b0fceee86687bd332e8ff498. ## Committee Appointment - Deborah Messemer: chair, Audit. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. - Elizabeth Barrett: member, Audit. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. - John DeYoung: member, Compensation. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. - Deborah Messemer: chair, Nominating and Governance. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. - Todd Sisitsky: member, Nominating and Governance. Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b. ## Security Listing - ALLO (NASDAQ). Claim: alpha:claim:company:0cdb3d9c-5598-43da-aed5-36b4bc6058b9:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df98055cad43227caad2761e4aa963bc386f8552b0fceee86687bd332e8ff498. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:df98055cad43227caad2761e4aa963bc386f8552b0fceee86687bd332e8ff498: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/allogene-therapeutics-inc). - alpha:projection-evidence:document:088abcb58187f0bf65350aa4e1b65e066582168bbf29eb5f975e8d3bf04b7890: [Allogene Therapeutics, Inc. DEF 14A 2025-04-30](https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm). - alpha:projection-evidence:document:d7ea16c416f6c284f251bd72e921ee2eccd63fbc43e9f19d4e0e1a1dd5d9f026: ALLO executive roster source. - alpha:projection-evidence:document:e359aa9adfd484ae58d99eb4dfb63c07024ecaf45119a809aaf1295f1b616d75: [ALLO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm). - alpha:projection-evidence:document:49f57b56db9669a6e5377a23b131b32c4f33cc0d52bccbd255a548a3fddfd7b9: [ALLO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm). - alpha:projection-evidence:document:7a8e53f8022fc4e59cc536d4294344629256f3aa587b4d4744b940d9713a75d0: [ALLO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm). - alpha:projection-evidence:4878b307deb15b2b7e0ecf267d5315684fa2409a0d1a1309c6236d905997326b: [Audit](https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/allogene-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/allogene-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/allogene-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/allogene-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T06:11:25.247217+00:00; recorded 2026-10-16T06:11:25.247217+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.